Project Grant R01MH139643
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant totaling $129,290 on August 22, 2025, under the Mental Health Research Grants program (CFDA 93.242). This research initiative, "Mapping Genotype to Developmental Course Across an Autism-Schizophrenia Gradient," will analyze phenotypic, genetic, and neurobiological data from over 43,000 participants and 1,900 postmortem human brain tissue donors to...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Boston Children's Hospital a Project Grant of $990,550 under the Mental Health Research Grants program (CFDA 93.242), effective March 10, 2026, with completion targeted for February 29, 2028. This R61/R33 phased research initiative will develop and test a computer-based cognitive control training program combined with metacognition coaching to reduce restricted and repetitive behaviors in school-aged children with...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant of $1.46M under the Mental Health Research Grants program (CFDA 93.242) effective September 15, 2025, through September 14, 2027. The grant funds research on "Effect of Network-Based Real Time Neurofeedback Augmentation of Mindfulness Practice on Recurrent Negative Thinking in Adolescents at Risk for Serious Mental Illness." The project addresses a...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Maryland, Baltimore a Project Grant totaling $762,566 under the Mental Health Research Grants program (CFDA 93.242), effective April 1, 2026 through December 31, 2030. This research initiative will generate comprehensive multi-omic and synaptic imaging data to advance understanding of cerebellar dysfunction in autism spectrum disorders (ASDs). The project will produce single-nuclei multi-omic...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant totaling $183,118 on September 1, 2025, under the Mental Health Research Grants program (CFDA 93.242). Under the direction of Dr. Tubbs, this research initiative will deliver integrated genomic and electronic health record (EHR) analyses designed to advance precision psychiatry by addressing critical gaps in translating genetic findings to clinical practice. The...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $844,917 under the Mental Health Research Grants program (CFDA 93.242), effective July 1, 2025, through April 30, 2030. The project, titled "Moderate Effect Size Genes in Autism Spectrum Disorder," delivers research services focused on identifying and characterizing moderate effect size (MES) risk genes that contribute to autism spectrum...
- Federal Grant Award Summary Massachusetts Institute of Technology received a $1,378,301 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded May 1, 2025, with a completion date of February 28, 2030. The grant funds fundamental neuroscience research investigating neuron-glial interactions in basal ganglia circuitry, specifically examining the role of striatal astrocytes in modulating dopamine signaling and...
- Federal Grant Award Summary Yale University received a $922,750 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective September 1, 2025 through August 31, 2027. The grant funds research titled "Characterizing Dynamic Neural Indices of Sound Sensitivity in Autism," which investigates the neurobiological mechanisms underlying auditory sensory difficulties experienced by approximately 70% of autistic...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $2.69 million Project Grant (CFDA 93.242—Mental Health Research Grants) to Massachusetts General Hospital, effective September 1, 2025 through May 31, 2030, to investigate early neurodevelopmental disparities among infants HIV-exposed uninfected (HEU) compared to HIV-unexposed (HU) infants. The research employs advanced brain ultrasound imaging technologies—including high-resolution microvascular imaging...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Southern California a $817,597 project grant effective September 19, 2025, through the Mental Health Research Grants program (CFDA 93.242) to develop machine learning prediction models for identifying autistic children and youth at risk for persistent adverse mental health outcomes. The research leverages social determinants of health (SDOH) extracted from electronic health record data at...
The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $824,728 Project Grant under the Mental Health Research Grants program (CFDA 93.242) on March 25, 2026, to support research characterizing intracortical feedforward and feedback sensory processes in Autism Spectrum Disorder (ASD). The project will employ a multimodal neuroimaging approach combining magnetoencephalography (MEG) with millisecond temporal resolution and highly novel submillimeter-resolution layer-specific 7-Tesla functional magnetic resonance imaging (fMRI) to map information flow along the auditory cortical hierarchy. The research will test the hypothesis that functional connectivity abnormalities in ASD stem from a fundamental imbalance between bottom-up (feedforward) and top-down (feedback) neural influences, examining 90 adults with ASD and 60 neurotypical adults ages 21–35 with average or above-average intelligence. The project, scheduled for completion by December 31, 2030, will generate advanced neuroimaging data, effective connectivity analyses, and mechanistic insights into sensory processing differences in ASD that may inform understanding of atypical behaviors characteristic of the disorder, including increased perceived salience of sensory stimuli and reduced top-down control. Research will be conducted at Massachusetts General Hospital's Research Management Division in Charlestown, Massachusetts, contributing to NIMH's mission of advancing understanding and treatment of mental illnesses through rigorous basic and clinical research.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $824.7k | 3/27/26 |